Marshall E - Search Results

1

Derivation of Breast Cancer Cell Lines Under Physiological (5%) Oxygen Concentrations.

Leung EY, Askarian-Amiri ME, Singleton DC, Ferraro-Peyret C, Joseph WR, Finlay GJ, Broom RJ, Kakadia PM, Bohlander SK, Marshall E, Baguley BC. Leung EY, et al. Among authors: marshall e. Front Oncol. 2018 Oct 12;8:425. doi: 10.3389/fonc.2018.00425. eCollection 2018. Front Oncol. 2018. PMID: 30370249 Free PMC article.

2

Comparison of responses of human melanoma cell lines to MEK and BRAF inhibitors.

Stones CJ, Kim JE, Joseph WR, Leung E, Marshall ES, Finlay GJ, Shelling AN, Baguley BC. Stones CJ, et al. Among authors: marshall es. Front Genet. 2013 May 8;4:66. doi: 10.3389/fgene.2013.00066. eCollection 2013. Front Genet. 2013. PMID: 23658559 Free PMC article.

3

Do negative feedback oscillations drive variations in the length of the tumor cell division cycle?

Baguley BC, Marshall E. Baguley BC, et al. Among authors: marshall e. Oncol Res. 2005;15(6):291-4. doi: 10.3727/096504005776404544. Oncol Res. 2005. PMID: 16408693

4

The use of human tumour cell lines in the discovery of new cancer chemotherapeutic drugs.

Baguley BC, Marshall ES. Baguley BC, et al. Expert Opin Drug Discov. 2008 Feb;3(2):153-61. doi: 10.1517/17460441.3.2.153. Expert Opin Drug Discov. 2008. PMID: 23480219

5

Anticancer drug sensitivity profiles of new and established melanoma cell lines.

Marshall ES, Holdaway KM, Shaw JH, Finlay GJ, Matthews JH, Baguley BC. Marshall ES, et al. Oncol Res. 1993;5(8):301-9. Oncol Res. 1993. PMID: 8012062

6

Short-term cultures of clinical tumor material: potential contributions to oncology research.

Baguley BC, Marshall ES, Finlay GJ. Baguley BC, et al. Among authors: marshall es. Oncol Res. 1999;11(3):115-24. Oncol Res. 1999. PMID: 10527071 Review.

7

Radiation-induced cell cycle delays and p53 status of early passage melanoma cell lines.

Parmar J, Marshall ES, Charters GA, Holdaway KM, Shelling AN, Baguley BC. Parmar J, et al. Among authors: marshall es. Oncol Res. 2000;12(3):149-55. doi: 10.3727/096504001108747620. Oncol Res. 2000. PMID: 11216673

8

Estimation of radiation-induced interphase cell death in cultures of human tumor material and in cell lines.

Marshall ES, Baguley BC, Matthews JH, Jose CC, Furneaux CE, Shaw JH, Kirker JA, Morton RP, White JB, Rice ML, Isaacs RJ, Coutts R, Whittaker JR. Marshall ES, et al. Oncol Res. 2004;14(6):297-304. doi: 10.3727/096504003773994833. Oncol Res. 2004. PMID: 15206492

9

Evidence for the involvement of p38 MAP kinase in the action of the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA).

Zhao L, Marshall ES, Kelland LR, Baguley BC. Zhao L, et al. Invest New Drugs. 2007 Jun;25(3):271-6. doi: 10.1007/s10637-006-9029-0. Epub 2007 Jan 3. Invest New Drugs. 2007. PMID: 17203401

10

Action of SN 28049, a new DNA binding topoisomerase II-directed antitumour drug: comparison with doxorubicin and etoposide.

Drummond CJ, Finlay GJ, Broome L, Marshall ES, Richardson E, Baguley BC. Drummond CJ, et al. Among authors: marshall es. Invest New Drugs. 2011 Oct;29(5):1102-10. doi: 10.1007/s10637-010-9473-8. Epub 2010 Jun 22. Invest New Drugs. 2011. PMID: 20567995

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,067 results

Search Page

Filters